Circulating miRNAs (e.g., miR-122, miR-34a) and epigenetic markers (e.g., HNF4A methylation) show promise for reflecting BPA-induced hepatic steatosis and ERα-mediated lipid dysregulation (127, 130). The gene discussed is HNF4A; the disease is Hepatic steatosis.